Specialty Societies Advancing Adult Immunization (SSAAI)
The Specialty Societies Advancing Adult Immunization (SSAAI) program is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award to the Council of Medical Specialty Societies (CMSS) totaling $41,508,742 with 100 percent funded by CDC/HHS. The contents are those of the authors and do not necessarily represent the official views of nor endorsement, by CDC/HHS or the U.S. Government.
Program Overview
A Cooperative Agreement with the Centers for Disease Control and Prevention
In September 2021, The Centers for Disease Control and Prevention (CDC) awarded a cooperative agreement to the Council of Medical Specialty Societies (CMSS), a coalition of over 50 specialty societies representing more than 800,000 physicians across healthcare to improve vaccination among high-risk adults. This five-year cooperative agreement currently includes $40.3 million in funding in the first three years to support increased COVID-19, influenza, and routine vaccinations in high-risk adults with chronic medical conditions. As part of the request for proposal, CDC specifically requested engagement of specialty society partners that care for patients with chronic obstructive pulmonary disease, asthma, diabetes, heart disease, cancer and chronic kidney disease, as well as older adults, and staff in occupational health settings.
Program Contacts
Sarah Imhoff, Senior Program Director
simhoff@cmss.org
Ashlan Ruth, Program Manager
aruth@cmss.org